Loading…
Imunon, Inc. is projected to decline to $2.12 by 2027, a -8% move from its current price of $2.30. IMNN is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.24 | $2.30 | $2.36 | 0.00% |
| May 30 | $2.22 | $2.30 | $2.39 | +0.01% |
| May 31 | $2.20 | $2.30 | $2.41 | +0.01% |
| Jun 1 | $2.18 | $2.30 | $2.42 | +0.02% |
| Jun 2 | $2.17 | $2.30 | $2.44 | +0.02% |
| Jun 3 | $2.16 | $2.30 | $2.45 | +0.03% |
| Jun 4 | $2.15 | $2.30 | $2.47 | +0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.15 | $2.30 | $2.47 | +0.03% |
| Week 2 | $2.09 | $2.30 | $2.54 | +0.07% |
| Week 3 | $2.04 | $2.30 | $2.60 | +0.10% |
| Week 4 | $2.00 | $2.30 | $2.65 | +0.13% |
| Week 5 | $1.97 | $2.30 | $2.69 | +0.17% |
| Week 6 | $1.94 | $2.30 | $2.73 | +0.20% |
| Week 7 | $1.92 | $2.31 | $2.77 | +0.23% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Imunon, Inc. is a clinical-stage biotechnology company focused on developing immunotherapies and vaccines in the United States. The company operates in the Healthcare sector and has a history of name changes, including its transition from Celsion Corporation to Imunon, Inc.
in September 2022. It was incorporated in 1982 and is headquartered in Lawrenceville, New Jersey.
Imunon, Inc. trades as a healthcare stock with a current price of $2.20. The company has a market capitalization of $9.24M and is ranked 5170 by market position. The stock’s latest price and market stance are complemented by a year-by-year forecast that shows a mix of near-term stability and longer-term upside.
A major floor 34.5% below — a decisive break under it would weaken the trend.
The nearest floor, 7.4% below — buyers have tended to step in here.
The nearest ceiling, 37.0% above — a clean break opens room to run.
A major ceiling 61.7% above — clearing it would confirm fresh momentum.
Key IMNN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of IMNN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.20 | Buy | $2.25 | Buy |
| MA 10 | $2.31 | Sell | $2.33 | Sell |
| MA 20 | $2.53 | Sell | $2.48 | Sell |
| MA 50 | $2.79 | Sell | $2.76 | Sell |
| MA 100 | $3.09 | Sell | $3.21 | Sell |
| MA 200 | $3.97 | Sell | $4.57 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 33.41 | Neutral |
| Stoch RSI (14) | 72.82 | Neutral |
| CCI (20) | -67.19 | Neutral |
| Williams %R (14) | -71.67 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -15.44 | Sell |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 28.33 | Neutral |
| TRIX (15) | -0.84 | Sell |
| Awesome (5,34) | -0.52 | Sell |
| Ultimate (7,14,28) | 28.77 | Buy |
| Momentum (10) | -0.40 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 2.18 | Buy |
| ADX (14) | 35.03 | Sell |
| ATR (14) | 0.06 | Info |
The near-term technical picture is neutral. The RSI14 sits at 20, reflecting a relatively quiet momentum. The stock’s simple moving averages show SMA50 at $2.82 and SMA200 at $4.01, suggesting a longer-term hurdle to overcome in relation to the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.13 | $2.30 | $3.05 | 0% | Neutral | |
| $1.69 | $2.12 | $2.82 | -8% | Neutral | |
| $1.84 | $2.38 | $3.27 | +3% | Neutral | |
| $2.08 | $2.73 | $3.87 | +19% | Neutral | |
| $2.08 | $2.80 | $4.05 | +22% | Bullish | |
| $2.19 | $2.99 | $4.41 | +30% | Bullish | |
| $2.08 | $2.90 | $4.36 | +26% | Bullish | |
| $2.01 | $2.84 | $4.34 | +24% | Bullish | |
| $2.08 | $2.98 | $4.63 | +30% | Bullish | |
| $1.99 | $2.89 | $4.55 | +26% | Bullish | |
| $2.56 | $3.96 | $6.61 | +72% | Bullish | |
| $4.13 | $7.12 | $13.00 | +210% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $2.13 | $2.30 | $2.69 | +0.00% |
| June 2026 | $1.91 | $2.24 | $2.69 | -2.70% |
| July 2026 | $1.95 | $2.31 | $2.81 | +3.23% |
| August 2026 | $2.01 | $2.39 | $2.94 | +3.45% |
| September 2026 | $1.98 | $2.36 | $2.93 | -1.07% |
| October 2026 | $1.97 | $2.37 | $2.95 | +0.15% |
| November 2026 | $2.02 | $2.44 | $3.06 | +2.99% |
| December 2026 | $1.99 | $2.42 | $3.05 | -0.88% |
Click any year to see its month-by-month IMNN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect IMNN to range from $2.13 to $3.05 through 2026. The $2.30 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The IMNN price prediction for 2027 points to an average of $2.12 (low $1.69, high $2.82) — a potential decline of -8% on today's $2.30. Price action looks broadly range-bound.
In 2028, IMNN is projected to trade between $1.84 and $3.27, averaging $2.38 — a potential gain of +3% from today's $2.30. That is up +12% on the projected 2027 average. A consolidation phase looks the most probable path here.
Imunon, Inc.'s 2029 outlook centres on $2.73, within a $2.08 to $3.87 range. That is up +15% on the projected 2028 average. That marks a +19% change versus current levels. Price action looks broadly range-bound.
By 2030, IMNN could reach as high as $4.05, with a base case around $2.80 and support toward $2.08 — roughly +22% from $2.30. Buyers look set to stay in control over this stretch.
Expect IMNN to range from $2.19 to $4.41 through 2031. The $2.99 average target implies a +30% move from current prices. That is up +7% on the projected 2030 average. Momentum favours further upside here.
The IMNN price prediction for 2032 points to an average of $2.90 (low $2.08, high $4.36) — a potential gain of +26% on today's $2.30. Buyers look set to stay in control over this stretch.
In 2033, IMNN is projected to trade between $2.01 and $4.34, averaging $2.84 — a potential gain of +24% from today's $2.30. That is -2% versus the projected 2032 average. Momentum favours further upside here.
Imunon, Inc.'s 2034 outlook centres on $2.98, within a $2.08 to $4.63 range. That is up +5% on the projected 2033 average. That marks a +30% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, IMNN could reach as high as $4.55, with a base case around $2.89 and support toward $1.99 — roughly +26% from $2.30. Momentum favours further upside here.
Expect IMNN to range from $2.56 to $6.61 through 2040. The $3.96 average target implies a +72% move from current prices. That is up +37% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The IMNN price prediction for 2050 points to an average of $7.12 (low $4.13, high $13.00) — a potential gain of +210% on today's $2.30. Momentum favours further upside here.
Investing $1,000 in IMNN today (≈ 434.782609 IMNN) could be worth
$3,097.77
+$2,097.77 (+210%) by 2050 · US Dollar
Based on the average projected IMNN price of $7.12 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in IMNNwould be worth at today's price.
$1,000 invested in IMNN on May 27, 2025 (≈ 33.773862 IMNN) would be worth
$77.68
-$922.32 (-92.2%) today · 0.08× · US Dollar
Based on a IMNN entry price of $29.61 vs. today's $2.3.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.13 | $1,079.81 | +8.0% |
| 1 month ago | $2.8 | $821.43 | -17.9% |
| 3 months ago | $3.16 | $727.85 | -27.2% |
| 6 months ago | $4.12 | $558.25 | -44.2% |
| 1 year ago | $29.61 | $77.68 | -92.2% |
| All time (5.0y) ago | $226.96 | $10.13 | -99.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our IMNN forecast.
Our base-case forecast reaches $4.60 around 2050.
Implied market cap at $4.60: $19.33M
The multi-year forecast depicts a bullish trajectory beginning in the 2030s. In 2026 the avg price is forecast at $2.20 with 0% ROI, turning negative in 2027 to -7.5% as the avg price slips to $2.04. The model turns bullish in the subsequent years, with 2030 avg $2.66 and ROI 20.9%, 2031 avg $2.86 and ROI 29.9%, and 2032 avg $2.76 with ROI 25.6%.
The path continues to 2033 avg $2.72 (ROI 23.6%), 2034 avg $2.86 (ROI 29.9%), and 2035 avg $2.75 (ROI 24.8%). In the longer horizon, 2040 shows avg $3.81 with ROI 73.2%, and 2050 shows avg $6.73 with ROI 205.9%, both labeled bullish. These figures reflect estimated price levels across years; they are not guarantees and carry inherent uncertainty and risk.
Tap a question to reveal the answer.
Avg $2.66, min $1.99, max $3.83; ROI 20.9%; sentiment BULLISH.
Forecasts show a mixed near term with 2027 ROI -7.5% and 2026 ROI 0%, but a bullish outlook from 2030 onward, with 2030–2050 ROIs of 20.9% to 205.9%. These are estimates, not guarantees.
Yes, the 2031 max is $4.20 and the 2034 max is $4.41, with other years showing higher max values (e.g., 2035 max $4.30, 2040 max $6.33, 2050 max $12.18). These are forecasted maxima and not guarantees.
Current price is $2.20 and market cap is $9.24M. The stock is ranked 5170.
Sentiment is NEUTRAL with RSI14 at 20. Support is at $2.13 and resistance at $3.15. The thirty-day range is $1.86 to $2.61, and annualized volatility is 50%.
Imunon, Inc. Community Discussion
0Share your Imunon, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.